Literature DB >> 11503777

Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule.

.   

Abstract

The Food and Drug Administration (FDA) is issuing a final rule to require human cells, tissue, and cellular and tissue-based product establishments to register with the agency and list their human cells, tissues, and cellular and tissue-based products. FDA is also amending the registration and listing regulations that currently apply to human cells, tissues, and cellular and tissue-based products regulated as drugs, devices, and/or biological products. These actions are being taken to establish a unified registration and listing program for human cells, tissues, and cellular and tissue-based products.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11503777

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

Review 1.  Regulation of hematopoietic stem cell processing and transplantation.

Authors:  Scott D Rowley
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 2.  Four Food and Drug Administration draft guidance documents and the REGROW Act: A litmus test for future changes in human cell- and tissue-based products regulatory policy in the United States?

Authors:  Kazuo Yano; Alessondra T Speidel; Masayuki Yamato
Journal:  J Tissue Eng Regen Med       Date:  2018-05-21       Impact factor: 3.963

3.  Decreasing latitude and increasing regulation in transplantable tissue programs.

Authors:  Linda Humphries
Journal:  AORN J       Date:  2005-11       Impact factor: 0.676

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.